UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13D
Under The Securities Exchange Act of 1934
(Amendment No. 1)*
MERIDIAN MEDICAL TECHNOLOGIES, INC.
- --------------------------------------------------------------------------------
(Name of Issuer)
Common Stock, par value $.10 per share
- --------------------------------------------------------------------------------
(Title of Class of Securities)
589658103
- --------------------------------------------------------------------------------
(CUSIP Number)
Steven Kaplan, Esq.
Arnold & Porter
555 Twelfth Street, N.W.
Washington, D.C. 20004-1202
(202) 942-5998
- --------------------------------------------------------------------------------
(Name, Address and Telephone Number of Person Authorized to
Receive Notices and Communications)
November 20, 1998
- --------------------------------------------------------------------------------
(Date of Event which Requires Filing of this Statement)
If the filing person has previously filed a statement on Schedule 13G to report
the acquisition which is the subject of this Schedule 13D, and is filing this
schedule because of Sections 240.13d-l(e), 240.13d-l(f) or 240.13d-l(g), check
the following box. |_|
Note: Schedules filed in paper format shall include a signed original and five
copies of the schedule, including all exhibits. See Section 240.13d-7 for other
parties to whom copies are being sent.
*The remainder of this cover shall be filled out for a reporting person's
initial filing on this form with respect to the subject class of securities, and
for any subsequent amendment containing information which would alter
disclosures provided in a prior cover page.
The information required on the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the Securities Exchange Act of
1934 ("Act") or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other provisions of the Act (however, see the
Notes).
This Document Consists of 4 Pages.
<PAGE>
CUSIP No. 589658103 Schedule 13D Page 4 of 1
- --------------------------------------------------------------------------------
1 NAME OF REPORTING PERSON
James H. Miller
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
- --------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) [ ]
(b) [ ]
- --------------------------------------------------------------------------------
3 SEC USE ONLY
- --------------------------------------------------------------------------------
4 SOURCE OF FUNDS*
- --------------------------------------------------------------------------------
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO
ITEMS 2(d) OR 2(e) [ ]
- --------------------------------------------------------------------------------
6 CITIZENSHIP OR PLACE OF ORGANIZATION
- --------------------------------------------------------------------------------
NUMBER OF 7 SOLE VOTING POWER
SHARES 233,461
BENEFICIALLY --------------------------------------------------------------
OWNED BY 8 SHARED VOTING POWER
EACH 0
REPORTING --------------------------------------------------------------
PERSON 9 SOLE DISPOSITIVE POWER
WITH 233,461
--------------------------------------------------------------
10 SHARED DISPOSITIVE POWER
0
- --------------------------------------------------------------------------------
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
233,461
- --------------------------------------------------------------------------------
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES*
[ ]
- --------------------------------------------------------------------------------
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
7.3%
- --------------------------------------------------------------------------------
14 TYPE OF REPORTING PERSON*
IN
- --------------------------------------------------------------------------------
*SEE INSTRUCTIONS BEFORE FILLING OUT!
<PAGE>
CUSIP No. 589658103 Schedule 13D Page 3 of 4
AMENDMENT 15 TO SCHEDULE 13D
----------------------------
The Schedule 13D, dated November 20, 1996, of James H. Miller (the
"Reporting Person") is hereby amended as set forth below.
The purpose of this Amendment No. 1 to Schedule 13D is to update
information regarding James H. Miller's holdings in securities of the issuer as
described herein. Except as specifically provided herein, this Amendment No. 1
to Schedule 13D does not modify any of the information previously reported in
the Schedule 13D, and should be read in conjunction with, and is qualified in
its entirety by reference to, the Schedule 13D.
Item 5 is hereby amended as set forth below:
Item 5. Interest in Securities of the Issuer
(a)-(b) Mr. Miller beneficially owns 233,461 shares of Common Stock,
which shares represent approximately 7.3% of the 2,991,080 shares of Common
Stock estimated to be outstanding, assuming the exercise by Mr. Miller of
options and warrants exercisable within 60 days of December 21, 1998. Of such
233,461 shares of Common Stock, 225,912 shares and 2,857 shares of Common Stock
are issuable upon the exercise of options and warrants, respectively. Mr. Miller
has the sole power to vote and dispose of the beneficially owned shares of
Common Stock. In addition, Mr. Miller holds options covering approximately
107,600 shares of Common Stock that will vest and become exercisable over time
in accordance with such options' terms.
On November 20, 1998, Mr. Miller transferred 16,654 shares of Common
Stock in a private transaction without consideration.
<PAGE>
CUSIP No. 589658103 Schedule 13D Page 4 of 4
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true, complete and
correct.
December 21, 1998 /s/ James H. Miller
----------------- ---------------------
(Date) James H. Miller
